PMID- 27896906
OWN - NLM
STAT- MEDLINE
DCOM- 20180226
LR  - 20180226
IS  - 1522-726X (Electronic)
IS  - 1522-1946 (Linking)
VI  - 89
IP  - 7
DP  - 2017 Jun 1
TI  - Identifying patients for safe early hospital discharge following st elevation 
      myocardial infarction.
PG  - 1141-1146
LID - 10.1002/ccd.26873 [doi]
AB  - OBJECTIVES: To examine whether the CADILLAC risk score is an effective method of 
      patient stratification for early discharge following ST elevation myocardial 
      infarction (STEMI). BACKGROUND: Patients with STEMI are typically hospitalized to 
      monitor for serious complications such as arrhythmias, heart failure, and 
      reinfarction. Optimal length of stay is unclear. Whether low risk patients can be 
      safely discharged before 72 hr of hospitalization is unclear. METHODS: Patients 
      with STEMI who underwent successful PCI were retrospectively stratified using 
      CADILLAC risk score to low risk (n = 123) and intermediate to high risk 
      (n = 105). The primary outcome was adverse clinical events at day 3 or later. 
      Secondary outcomes were adverse clinical events on day 1 and mortality rates at 
      30 days and 31 to 365 days. RESULTS: Low risk patients had lower major adverse 
      clinical events at day 3 or later (0 vs. 11.4%, P = 0.0002) and lower total 
      mortality at 1 year (0 vs. 4.8%, P = 0.02) than patients with intermediate to 
      high risk. Low risk patients were also less likely to have a cardiovascular event 
      during the first 24 hr when compared to those with an intermediate to high risk 
      score (3.3% vs. 13.3%, P = 0.006). CONCLUSION: Low risk patients identified using 
      CADILLAC risk score with STEMI treated successfully with primary PCI have a low 
      adverse event rate on the third day or later of hospitalization suggesting that 
      an earlier discharge is safe in properly selected patients. Monitoring in a 
      noncritical care setting following primary PCI for STEMI may be feasible for 
      selected patients. (c) 2016 Wiley Periodicals, Inc.
CI  - (c) 2016 Wiley Periodicals, Inc.
FAU - Sharkawi, Musa A
AU  - Sharkawi MA
AD  - Department of Cardiovascular Medicine, Hartford Hospital, Hartford, Connecticut.
AD  - University of Connecticut School of Medicine, Farmington, Connecticut.
FAU - Filippaios, Andreas
AU  - Filippaios A
AD  - Department of Internal Medicine, Lahey Hospital & Medical Center, Burlington, 
      Massachusetts.
FAU - Dani, Saurabh S
AU  - Dani SS
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
FAU - Shah, Sachin P
AU  - Shah SP
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
AD  - Tufts University School of Medicine, Boston, Massachusetts.
FAU - Riskalla, Nabila
AU  - Riskalla N
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
FAU - Venesy, David M
AU  - Venesy DM
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
AD  - Tufts University School of Medicine, Boston, Massachusetts.
FAU - Labib, Sherif B
AU  - Labib SB
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
AD  - Tufts University School of Medicine, Boston, Massachusetts.
FAU - Resnic, Frederic S
AU  - Resnic FS
AD  - Department of Cardiovascular Medicine, Lahey Hospital & Medical Center, 
      Burlington, Massachusetts.
AD  - Tufts University School of Medicine, Boston, Massachusetts.
LA  - eng
PT  - Journal Article
DEP - 20161129
PL  - United States
TA  - Catheter Cardiovasc Interv
JT  - Catheterization and cardiovascular interventions : official journal of the 
      Society for Cardiac Angiography & Interventions
JID - 100884139
SB  - IM
CIN - Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1147-1148. PMID: 28612413
MH  - Aged
MH  - Aged, 80 and over
MH  - *Decision Support Techniques
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - *Length of Stay
MH  - Male
MH  - Middle Aged
MH  - *Patient Discharge
MH  - Patient Selection
MH  - *Percutaneous Coronary Intervention/adverse effects/mortality
MH  - Predictive Value of Tests
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Risk Factors
MH  - ST Elevation Myocardial Infarction/*diagnosis/mortality/*therapy
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - acute myocardial infarction/ST elevation myocardial infarction
OT  - economica/cost-effectiveness
OT  - percutaneous coronary intervention
EDAT- 2016/11/30 06:00
MHDA- 2018/02/27 06:00
CRDT- 2016/11/30 06:00
PHST- 2016/07/21 00:00 [received]
PHST- 2016/11/06 00:00 [accepted]
PHST- 2016/11/30 06:00 [pubmed]
PHST- 2018/02/27 06:00 [medline]
PHST- 2016/11/30 06:00 [entrez]
AID - 10.1002/ccd.26873 [doi]
PST - ppublish
SO  - Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1141-1146. doi: 10.1002/ccd.26873. 
      Epub 2016 Nov 29.